Literature DB >> 23216121

Analysis of losartan and carvedilol in urine and plasma samples using a dispersive liquid-liquid microextraction isocratic HPLC-UV method.

Somaieh Soltani1, Amir M Ramezani, Naser Soltani, Abolghasem Jouyban.   

Abstract

BACKGROUND: A simple, precise and sensitive HPLC method has been developed for simultaneous determination of carvedilol and losartan in human plasma and urine samples. The analytes were extracted by a dispersive liquid-liquid microextraction method. A mobile phase of 15 mM sodium dihydrogen phosphate buffer (pH 4.0)/acetonitrile/2-propanol (70/27.5/2.5, v/v/v) was used to separate the drugs using a Waters® ODS column (250 × 4.6 mm) and detected by a UV detector at 222 nm.
RESULTS: The developed method is selective for studied drugs possessing a linearity range of 0.1-1.0 and 0.05-0.75 µg/ml, respectively, for losartan and carvedilol with precision <15%. The accuracy is better than 15% and the mean recovery of carvedilol and losartan was 98.9 and 100.2% for plasma and 100.7 and 100.5% for urine samples, respectively.
CONCLUSION: The developed method is applicable for therapeutic drug monitoring and PK analyses.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23216121     DOI: 10.4155/bio.12.261

Source DB:  PubMed          Journal:  Bioanalysis        ISSN: 1757-6180            Impact factor:   2.681


  2 in total

1.  Ionic liquid phase microextraction combined with fluorescence spectrometry for preconcentration and quantitation of carvedilol in pharmaceutical preparations and biological media.

Authors:  Mohsen Zeeb; Behrooz Mirza
Journal:  Daru       Date:  2015-04-30       Impact factor: 3.117

2.  Determination of Levetiracetam in Human Plasma by Dispersive Liquid-Liquid Microextraction Followed by Gas Chromatography-Mass Spectrometry.

Authors:  Greyce Kelly Steinhorst Alcantara; Leandro Augusto Calixto; Luiz Alberto Beraldo de Moraes; Regina Helena Costa Queiroz; Anderson Rodrigo Moraes de Oliveira; Cristiane Masetto de Gaitani
Journal:  J Anal Methods Chem       Date:  2016-10-17       Impact factor: 2.193

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.